Dirk Klingbiel

Prognostic Role of <i>KRAS</i> and <i>BRAF</i> in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial

Arnaud Roth, Sabine Tejpar, Mauro Delorenzi et al. · Journal of Clinical Oncology · 2009 · 1.2K citations · Full text

Medicine, Oncology, Surgery +17

Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features

Edoardo Missiaglia, Bart Jacobs, G. d'Ario et al. · Annals of Oncology · 2014 · 670 citations · Full text

Medicine, Oncology, Pathology +14

Integrated Analysis of Molecular and Clinical Prognostic Factors in Stage II/III Colon Cancer

A. Roth, Mauro Delorenzi, Sabine Tejpar et al. · JNCI Journal of the National Cancer Institute · 2012 · 280 citations · Full text

Medicine, Biostatistics, Oncology +15

Prognosis of stage II and III colon cancer treated with adjuvant 5-fluorouracil or FOLFIRI in relation to microsatellite status: results of the PETACC-3 trial

Dirk Klingbiel, Zacharenia Saridaki, A. Roth et al. · Annals of Oncology · 2014 · 237 citations · Full text

Medicine, Oncology, Chemotherapy +14

Final Results of a Prospective Evaluation of the Predictive Value of Interim Positron Emission Tomography in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP-14 (SAKK 38/07)

Christoph Mamot, Dirk Klingbiel, Felicitas Hitz et al. · Journal of Clinical Oncology · 2015 · 189 citations

Medicine, Nuclear Medicine, Oncology +16